Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;52(1):126-9.
doi: 10.1136/gut.52.1.126.

Impact of smoking on histological liver lesions in chronic hepatitis C

C Hézode  1 , I Lonjon, F Roudot-Thoraval, J-P Mavier, J-M Pawlotsky, E S Zafrani, D Dhumeaux
Affiliations

Impact of smoking on histological liver lesions in chronic hepatitis C

C Hézode et al. Gut. 2003 Jan.

Abstract

Aims and methods: To examine the association between smoking and histological liver lesions in chronic hepatitis C, we studied 244 consecutive patients (152 men, 92 women; mean age 45.9 (12.6) years) with histologically proven chronic hepatitis C. Daily tobacco consumption during the six months preceding liver biopsy was recorded as the number of cigarettes smoked daily. Total lifetime tobacco consumption was recorded as the number of cigarette packs smoked per year (packs-years). Liver biopsy specimens were graded for histological activity and fibrosis according to the METAVIR scoring system.

Results: The proportion of patients with moderate (A2) or marked (A3) activity increased gradually from 62.0% in non-smokers to 81.7% in patients who smoked more than 15 cigarettes per day (p<0.009). A similar relationship was observed with total lifetime tobacco consumption: 59.0% of patients who had never smoked had grade A2 or A3 disease activity compared with 84.6% of patients who smoked more than 20 packs per year (p<0.002). Multivariate analysis showed that age over 50 years (odds ratio (OR) 5.4), alcohol intake exceeding 20 g/day (OR 2.75), and tobacco consumption of more than 15 cigarettes/day (OR 3.6) were independently related to the histological activity score. No relationship was found between the severity of fibrosis and either daily tobacco consumption or total lifetime tobacco consumption. Multivariate analysis showed that only age over 50 years (OR 8.8), daily alcohol intake exceeding 30 g/day (OR 3.4), and histological activity score (OR 7.9) were independently related to the fibrosis score.

Conclusion: This study suggests that smoking, independent of alcohol, could aggravate the histological activity of chronic hepatitis C and that patients with chronic hepatitis C virus infection should be advised to reduce or stop smoking.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between histological activity (METAVIR scoring system; A1=mild to A3=marked) and smoking (cig/day within the six months before biopsy) in patients with chronic hepatitis C virus infection (p<0.009, test for a linear trend).
Figure 2
Figure 2
Relationship between histological activity (METAVIR scoring system; A1=mild to A3=marked) and smoking (packs-years) in patients with chronic hepatitis C virus infection (p<0.002, test for a linear trend).
Figure 3
Figure 3
Relationship between alcohol intake (g/day) and tobacco consumption (cig/day within the six months before biopsy) in patients with chronic hepatitis C virus infection (p<0.001).
Figure 4
Figure 4
Relationship between histological fibrosis (METAVIR scoring system; F0=no fibrosis to F4=cirrhosis) and smoking (cig/day within the six months before biopsy) in patients with chronic hepatitis C virus infection (p<0.51, test for a linear trend).
Figure 5
Figure 5
Relationship between histological fibrosis (METAVIR scoring system; F0=no fibrosis to F4=cirrhosis) and smoking (packs-years) in patients with chronic hepatitis C virus infection (p=0.11).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999;30:956–61. - PubMed
    1. Roudot-Thoraval F, Pawlotsky JM, Deforges L, et al. Anti-HCV seroprevalence in pregnant women in France. Gut 1993;34(suppl 2):S55–6. - PMC - PubMed
    1. Kiyosawa K, Tanaka E, Sodeyama T, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 1994;106:1596–602. - PubMed
    1. Tong MJ, El-Farra NS, Reikes A, et al. Clinical outcomes after transfusion associated hepatitis C. N Engl J Med 1995;332:1463–6. - PubMed
    1. Roudot-Thoraval F, Bastie A, Pawlotsky JM, et al. Epidemiological factors affecting the severity of hepatitis C virus related liver disease: a French survey of 6664 patients. Hepatology 1997;26:485–90. - PubMed